New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
08:59 EDTOFIXOrthofix reports preliminary Q2 revenue $101.3M, consensus $99.20M
Orthofix International announced that it is delaying the release of its financial results for Q2. The company requires additional time to evaluate certain items primarily related to entries contained in the previous restatement of its prior periods’ financial results. The company said, "While it is unfortunate we have discovered items that require additional analysis in certain previous restatement entries, considering the complexity of our prior restatement, the identification of potential technical errors is understandable. We look forward to finalizing the analysis as quickly as possible and bringing the investment community up to date on the recent performance of the business. There may be changes to historical net sales and net income totals, but we expect that the factors causing these revisions, if any, will have little or no effect on the underlying performance of the business going forward.” Reports preliminary Q2 BioStim net sales $39.8M. Reports preliminary Q2 Biologics net sales $13.9M. Reports Q2 preliminary Extremity Fixation net sales $27.3M. Reports preliminary Q2 Spine Fixation net sales $20.2M.
News For OFIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
06:42 EDTOFIXOrthofix enters into acquisition agreement with eNeura
Subscribe for More Information
06:36 EDTOFIXOrthofix announces filing of restated financial statements
Orthofix filed with the SEC restated financial statements for fiscal years 2011, 2012 and 2013 and the fiscal quarter ended March 31, 2014, while also filing its late Quarterly Reports on Form 10-Q for the fiscal quarters ended June 30, 2014 and September 30, 2014. The Company continues to work to complete the procedures needed to file its 2014 Annual Report on Form 10-K with the Securities and Exchange Commission. As requested by a letter from NASDAQ, on March 25, 2015, the Company provided a written update to the Hearings Panel regarding these matters. The Company has requested that the Hearings Panel grant the Company relief from delisting through April 30, 2015 while it completes the filing of its 2014 Annual Report on Form 10-K.
06:34 EDTOFIXOrthofix reports 3Q14 adjusted EPS 17c, revenue $100.99M
Subscribe for More Information
March 17, 2015
13:06 EDTOFIXOrthofix files to delay Form 10-K
As previously disclosed, the company is continuing to prepare restated financial statements for the fiscal years ended December 31, 2013, 2012 and 2011, including the interim quarterly periods contained within the fiscal years ended December 31, 2013 and 2012, and the fiscal quarter ended March 31, 2014. In addition, the company is continuing to prepare its delayed Quarterly Reports for the fiscal quarters ended June 30, 2014 and September 30, 2014, which will contain restated consolidated interim financial statements for the fiscal quarters ended June 30, 2013 and September 30, 2013, respectively. As a result of this process, the company is not yet able to file its annual report on Form 10-K for the fiscal year ended December 31, 2014. The company is working expeditiously to complete the restatement and each of the aforementioned filings, including the 2014 Form 10-K, as soon as practicable.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use